Results 181 to 190 of about 117,026 (248)

Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs. [PDF]

open access: yesFront Endocrinol (Lausanne), 2019
Gadelha M   +10 more
europepmc   +1 more source

Corrigendum: Estrogens modulate somatostatin receptors expression and synergize with the somatostatin analog pasireotide in prostate cells

open access: yesFrontiers in Pharmacology
Valentina Rossi   +8 more
doaj   +1 more source

Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs. [PDF]

open access: yesOncologist, 2019
Kiesewetter B   +7 more
europepmc   +1 more source

A review of the use of somatostatin analogs in oncology

open access: yesOncoTargets and Therapy, 2013
Somatostatin is a neuropeptide produced by paracrine cells that are located throughout the gastrointestinal tract, lung, and pancreas, and is also found in various locations of the nervous system.
Suayib Yalcin, Özge Keskin
exaly   +2 more sources

Somatostatin Receptors in Non-Neuroendocrine Malignancies: The Potential Role of Somatostatin Analogs in Solid Tumors

open access: yesFuture Oncology, 2011
Somatostatin receptors (sstrs) are G-protein-coupled receptors that mediate various physiological effects when activated by the neuropeptide somatostatin or its synthetic analogs.
Herbert A Schmid, Jens Hasskarl
exaly   +2 more sources

Home - About - Disclaimer - Privacy